Follow
Margie Moczygemba
Margie Moczygemba
Research Associate Professor, Texas A&M Health Science Center
Verified email at tamu.edu - Homepage
Title
Cited by
Cited by
Year
Mutations in 5-methylcytosine oxidase TET2 and RhoA cooperatively disrupt T cell homeostasis
S Zang, J Li, H Yang, H Zeng, W Han, J Zhang, M Lee, M Moczygemba, ...
The Journal of clinical investigation 127 (8), 2998-3012, 2017
882017
Nucleus-mitochondria positive feedback loop formed by ERK5 S496 phosphorylation-mediated poly (ADP-ribose) polymerase activation provokes persistent pro-inflammatory senescent …
S Kotla, A Zhang, M Imanishi, KA Ko, SH Lin, YJ Gi, M Moczygemba, ...
Redox Biology 47, 102132, 2021
242021
PBRM1 loss reduces IFNγ-STAT1 activity and promotes resistance to immunotherapy and antiangiogenic therapy in renal cell carcinoma
X Liu, W Kong, C Peterson, A Hoang, X Zhang, L Zhou, P Pilie, T Lam, ...
Cancer Research 79 (13_Supplement), 945-945, 2019
12019
PBRM1 loss promotes resistance to immunotherapy in RCC.
XD Liu, W Kong, A Hoang, X Zhang, L Zhou, PG Pilie, S Isgandrova, ...
CANCER IMMUNOLOGY RESEARCH 8 (4), 105-105, 2020
2020
Abstract B48: PBRM1 loss promotes resistance to immunotherapy in RCC
XD Liu, W Kong, A Hoang, X Zhang, L Zhou, PG Pilie, S Isgandrova, ...
Cancer Immunology Research 8 (4_Supplement), B48-B48, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–5